$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
托珠单抗用于治疗COVID-19重症患者在欧获批!
2025-10-19 11:44:20
Check Details
奥密克戎正以前所未有速度传播,辉瑞新口服药对其有效!
2025-10-19 11:44:20
Check Details
辉瑞公司表示,其COVID口服药Paxlovid似乎对Omicron变体有效
2025-10-19 11:44:20
Check Details
新冠口服药莫努匹韦最新研究结果:早期治疗可显著降低住院和死亡风险
2025-10-19 11:44:20
Check Details
FDA的独立研究显示,长效抗体组合Evusheld对Omicron变体保持了中和活性
2025-10-19 11:44:20
Check Details
首个FDA授权新冠口服药:FDA授予新冠口服药PAXLOVID™紧急使用授权
2025-10-19 11:44:20
Check Details
瑞德西韦最新数据公布!可显著降低COVID-19高危患者的住院风险
2025-10-19 11:44:20
Check Details
Evusheld长效抗体组合保留了对Omicron变体的中和活性
2025-10-19 11:44:20
Check Details
喜讯!抗击COVID-19的鼻喷剂即将进入临床试验
2025-10-19 11:44:20
Check Details
冠状病毒可以在感染数天后传播到心脏、大脑
2025-10-19 11:44:20
Check Details
莫努匹韦的安全性和疗效怎么样?国内哪里能买到莫努匹韦?
2025-10-19 11:44:20
Check Details
莫努匹韦应该怎么服用?莫努匹韦需要注意什么?
2025-10-19 11:44:20
Check Details
1
2
...
3423
3424
3425
3426
3427
3428
3429
...
10241
10242
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Key points for drug monitoring of Molotinib in bone marrow fibrosis
2
Elacestrant US Approval and Treatment Planning While Not Yet Available Locally
3
Stiripentol in Dravet Syndrome: Growth, Cognitive Development and Long-Term Follow-Up Management
4
FDA Approves Pimicotinib for Symptomatic Tenosynovial Giant Cell Tumor: Mechanism, Dosing and MANEUVER Data
5
Cabozantinib Overview: Multi-Target TKI Efficacy and Safety Monitoring for Bleeding, Hypertension, Thrombosis
6
FDA Approves Sunharbo (asundexian), the World’s First FXIa Inhibitor, to Reduce Stroke Risk in Adults with Recent Non‑Cardioembolic Ischemic Stroke or High‑Risk TIA
7
Sotorasib (Lumakras): Indications, Dosing, Safety and the Next-Gen KRAS G12C Landscape
8
Momelotinib for Myelofibrosis: Spleen Response, Symptom Improvement and Efficacy Monitoring
9
Pirtobrutinib and Risks of Atrial Fibrillation and Bleeding: Mechanism, Data Interpretation and Monitoring
10
Weight Gain and Edema Management, Monitoring of Repotrectinib (Augtyro) During Treatment
11
Ixazomib (Ninlaro) Dosing Schedule, Missed Dose Management and Cycle Planning in 28‑Day Regimen
12
Ponatinib in the PACE Phase II Trial: Response Data in Resistant CML and Ph+ ALL